Moderna CEO on Earnings, Flu Shots and Skin Cancer Trials
Moderna’s first-quarter sales beat expectations, as the struggling vaccine maker that’s faced resistance from the Trump administration has found new growth outside the US. Moderna CEO Stephane Bancel sits down with Bloomberg's Katie Greifeld, saying the company's skin cancer trial results should arrive this year. (Source: Bloomberg)
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.